Μaria Dalamaga

12.1k total citations · 7 hit papers
225 papers, 7.9k citations indexed

About

Μaria Dalamaga is a scholar working on Epidemiology, Physiology and Molecular Biology. According to data from OpenAlex, Μaria Dalamaga has authored 225 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Epidemiology, 50 papers in Physiology and 43 papers in Molecular Biology. Recurrent topics in Μaria Dalamaga's work include Adipokines, Inflammation, and Metabolic Diseases (36 papers), Diet and metabolism studies (21 papers) and Adipose Tissue and Metabolism (15 papers). Μaria Dalamaga is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (36 papers), Diet and metabolism studies (21 papers) and Adipose Tissue and Metabolism (15 papers). Μaria Dalamaga collaborates with scholars based in Greece, United States and Denmark. Μaria Dalamaga's co-authors include Christos S. Mantzoros, Ιrene Karampela, Gerasimos Socrates Christodoulatos, Nikolaos Spyrou, Natalia G. Vallianou, Konstantinos Avgerinos, Theodora Stratigou, Kalliope N. Diakopoulos, Evangelia Papadavid and Κωνσταντίνος Καρμανιώλας and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Μaria Dalamaga

216 papers receiving 7.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity and cancer risk: Emerging biological mechanisms and perspectives

2018 1.0k citations Nikolaos Spyrou, Μaria Dalamaga et al. profile →
The Role of Adiponectin in Cancer: A Review of Current Evidence

2012 478 citations Μaria Dalamaga et al. profile →
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives

2021 206 citations Natalia G. Vallianou, Gerasimos Socrates Christodoulatos et al. Biomolecules profile →
Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten?

2023 179 citations Μaria Dalamaga et al. Current Obesity Reports profile →
Obesity Paradox: Fact or Fiction?

2023 86 citations Alexander Kokkinos, Μaria Dalamaga et al. Current Obesity Reports profile →
The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and Controversies

2024 59 citations Μaria Dalamaga, Dimitrios Tsilingiris et al. profile →
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD

2024 53 citations Μaria Dalamaga et al. Current Obesity Reports profile →

Peers

Μaria Dalamaga

EPIDE

PHYSI

ONCOL

Dorine W. Swinkels Netherlands

Claudio Pelucchi Italy

Shin‐Wook Kang South Korea

Grace L. Su United States

Jean‐Philippe Bastard France

Xueqing Yu China

Robert D. Christensen United States

Barbara McKnight United States

Oswald Wagner Austria

Shirish Barve United States

Dorine W. Swinkels Netherlands

Μaria Dalamaga

1.1k ×0.4

EPIDE

1.4k ×0.7

PHYSI

2.5k ×1.3

649 ×0.4

ONCOL

942 ×1.0

Citations per year, relative to Μaria Dalamaga Μaria Dalamaga (= 1×) peers Dorine W. Swinkels

Countries citing papers authored by Μaria Dalamaga

Since Specialization

Citations

This map shows the geographic impact of Μaria Dalamaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Μaria Dalamaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Μaria Dalamaga more than expected).

Fields of papers citing papers by Μaria Dalamaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Μaria Dalamaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Μaria Dalamaga. The network helps show where Μaria Dalamaga may publish in the future.

Co-authorship network of co-authors of Μaria Dalamaga

This figure shows the co-authorship network connecting the top 25 collaborators of Μaria Dalamaga. A scholar is included among the top collaborators of Μaria Dalamaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Μaria Dalamaga. Μaria Dalamaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Argyrakopoulou, Georgia, et al.. (2025). Obesity and the Gut-Brain Axis in Type 1 Diabetes Mellitus: Terra Incognita?. Current Obesity Reports. 14(1). 61–61. 1 indexed citations

Georgakopoulou, Vasiliki, Athina Lazaridou, Athanasios Voulgaris, et al.. (2025). Sleep quality and well-being in obesity-hypoventilation syndrome versus obstructive sleep apnea with obesity: A comparative study. Metabolism Open. 26. 100367–100367.

Vallianou, Natalia G., Μaria Dalamaga, Eleni Rebelos, et al.. (2025). The Transformative Role of Nanotechnology in the Management of Diabetes Mellitus: Insights from Current Research. Biomolecules. 15(5). 653–653. 1 indexed citations

Mangano, Katia, Natalia G. Vallianou, Theodora Stratigou, et al.. (2024). Serum and urinary levels of MIF, CD74, DDT and CXCR4 among patients with type 1 diabetes mellitus, type 2 diabetes and healthy individuals: Implications for further research. SHILAP Revista de lepidopterología. 24. 100320–100320. 1 indexed citations

Kounatidis, Dimitris, Natalia G. Vallianou, Angelos Evangelopoulos, et al.. (2024). ApoB100 and Atherosclerosis: What’s New in the 21st Century?. Metabolites. 14(2). 123–123. 18 indexed citations

Vallianou, Natalia G., et al.. (2024). Vaccination as a Promising Approach in Cardiovascular Risk Mitigation: Are We Ready to Embrace a Vaccine Strategy?. Biomolecules. 14(12). 1637–1637. 2 indexed citations

Karampela, Ιrene, Natalia G. Vallianou, Dimitrios Tsilingiris, et al.. (2024). Alterations of the Adipo–Myokine Irisin in Sepsis and Septic Shock: Diagnostic and Prognostic Implications. Biomolecules. 14(3). 291–291. 5 indexed citations

Geladari, Eleni, Natalia G. Vallianou, Angelos Evangelopoulos, et al.. (2024). Cardiac Troponin Levels in Patients with Chronic Kidney Disease: “Markers of High Risk or Just Noise’’?. Diagnostics. 14(20). 2316–2316. 3 indexed citations

Kounatidis, Dimitris, Nikolaοs Tentolouris, Natalia G. Vallianou, et al.. (2024). The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies. Metabolites. 14(7). 388–388. 6 indexed citations

10.

Lempesis, Ioannis, et al.. (2023). Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome. Diabetes/Metabolism Research and Reviews. 39(6). e3682–e3682. 12 indexed citations

11.

Tsilingiris, Dimitrios, Nikolaos Spyrou, Natalia G. Vallianou, et al.. (2023). Obesity and main urologic cancers: Current systematic evidence, novel biological mechanisms, perspectives and challenges. Seminars in Cancer Biology. 91. 70–98. 28 indexed citations

12.

Karampela, Ιrene, Natalia G. Vallianou, Dimitrios Tsilingiris, et al.. (2023). Diagnostic and Prognostic Value of Serum Omentin-1 in Sepsis: A Prospective Study in Critically Ill Patients. Medicina. 59(5). 833–833. 9 indexed citations

13.

Argyrakopoulou, Georgia, et al.. (2023). Revisiting Resting Metabolic Rate: What is the Relation to Weight Fluctuations?. Current Obesity Reports. 12(4). 502–513. 10 indexed citations

14.

Karampela, Ιrene, Gerasimos Socrates Christodoulatos, Natalia G. Vallianou, et al.. (2022). Circulating Chemerin and Its Kinetics May Be a Useful Diagnostic and Prognostic Biomarker in Critically Ill Patients with Sepsis: A Prospective Study. Biomolecules. 12(2). 301–301. 20 indexed citations

15.

Argyrakopoulou, Georgia, Μaria Dalamaga, Nikolaos Spyrou, & Alexander Kokkinos. (2021). Gender Differences in Obesity-Related Cancers. Current Obesity Reports. 10(2). 100–115. 56 indexed citations

16.

Karampela, Ιrene, et al.. (2021). The effect of COVID-19 pandemic on the attendance and clinical outcomes of patients with ophthalmic disease: A mini-review. SHILAP Revista de lepidopterología. 12. 100131–100131. 8 indexed citations

17.

Christodoulatos, Gerasimos Socrates, Georgios Antonakos, Ιrene Karampela, et al.. (2021). Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study. Biomolecules. 11(11). 1609–1609. 25 indexed citations

18.

Dalamaga, Μaria, et al.. (2021). A Narrative Review of the Safety of Anti-COVID-19 Nutraceuticals for Patients with Cancer. Cancers. 13(23). 6094–6094. 6 indexed citations

19.

Karampela, Ιrene, et al.. (2020). The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19. SHILAP Revista de lepidopterología. 8. 100066–100066. 56 indexed citations

20.

Dalamaga, Μaria, et al.. (2020). Comorbidities burden and previous exposure to biological agents may predict drug survival of apremilast for psoriasis in a real‐world setting. Dermatologic Therapy. 33(6). e14168–e14168. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact